About this trial
The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients able to understand and sign the informed consent form.
Documented HIV-1 infection.
Under the first line TLD for at least 6 months.
At least 3 months follow-up with CV >200c/ml.
Disqualifiers
Patients <18 years of age.
Under the first line regime other than TLD.
Patients with active neoplastic processes.
Patients with active opportunistic diseases.
Trial population
HIV-1 infected men or women \>18 years controlled in the day care center of Chokwé Hospital
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not applicable- observational study
Other interventionNot applicable- observational study
Treatment groups
Trial outcomes
Primary outcomes
Selection of DRM to dolutegravir and/or tenofovir and/or lamivudine
% of Selection of DRM to dolutegravir and/or tenofovir and/or lamivudine
Sponsors and contacts
Click on the lead sponsor to view all of their trials.